pharma · Neurogenic Detrusor Overactivity
Astellas Pharma
Astellas Pharma Europe B. V.
Astellas Pharma patent portfolio — 10 USPTO pharmaceutical patents (A61K/A61P) with grant dates, status, and loss-of-exclusivity filters.
Company details
- Status
- Public
- HQ
- JP
- Employees
- 12,378
- Programs
- 1
- Drugs
- 2
- Patents
- 10
Astellas Pharma patents
10 pharmaceutical patents indexed for Astellas Pharma. 0 expire within 24 months.
Astellas Pharma has 10 pharmaceutical patents in our USPTO PatentsView index (A61K/A61P). 0 expire within 24 months — use filters for patent-cliff planning.
Patent portfolio
-
CN 120418289
Combination therapy of bispecific binding agents that bind to CLDN18.2 and CD3 with immune checkpoint inhibitors
granted -
KR 20240032847
CLDN18.2 및 CD3에 결합하는 이중특이 결합제
granted -
CN 105120840
Composition of tiacumicin compounds
granted -
EP 1549658
VERBINDUNGEN AUF GLUKOSEBASIS MIT AFFINITÜT FÜR P-SELEKTIN
expired -
EP 1527086
VERBINDUNGEN DIE P-SELECTIN BINDEN
expired -
EP 1423413
SELEKTIV P-SELECTIN BINDENDE PEPTIDISCHE VERBINDUNGEN
expired -
EP 1392755
ZUSAMMENSETZUNGEN ENTHALTEND LIPID-POLYMER KONJUGATE
expired -
IS 5505
Notkun á blöndu díóls og alfa-hýdroxýsýru til að meðhöndla sjúkdóma sem lýsa sér í ofvexti í hornlagi húðþekju
expired -
HU P9903958
INSTANT VESICULAR PRODUCT
expired -
HU P9903308
GRANULS FOR THE PREPARATION OF FAST-DISINTEGRATING AND FAST-DISSOLVING COMPOSITIONS CONTAINING A HIGH AMOUNT OF DRUG
expired
Frequently asked questions
How many patents does Astellas Pharma have?
10 published patents match the current filter (all indexed). The full portfolio is indexed from USPTO PatentsView (A61K/A61P).
When do Astellas Pharma patents expire?
0 patents in the full portfolio expire within 24 months. Use the expiring filters above or open individual patent pages for grant and expiration dates.